9 results
Causes of Fatigue - Differential Diagnosis Algorithm
Endocrine
 • Hypo/Hyperthyroidism
 • Diabetes
 • Pituitary Insufficiency
 • Adrenal
Causes of Fatigue ... Neoplastic / Hematologic ... Chronic Obstructive Pulmonary ... Myasthenia Gravis Pharmacologic ... • Drug Abuse (e.g
Vasopressors Table 
Rough properties by Target Receptor, Heart Rate/Inotropy, Systemic Vascular Resistance, Cardiac Output, Blood Pressure,
Blood Pressure, Pulmonary ... Resistance, Main Uses ... /kg/min - Milrinone ... Properties #Table #Pharmacology ... #Effect #Management
Hydroxychloroquine Serum Measurement in SLE
 • Terminal elimination half-life = 40 days ([HCQI reflects long-term intake)
• Special cases ... (e.g. renal failure ... Measurement #SLE #rheumatology ... #pharmacology # ... levels #lupus #management
Treatment of Stable Narrow-Complex Tachycardia
Regular Rhythm:
 • Attempt vagal maneuvers
 • Give adenosine 6 milligrams IV
Control rate (e.g ... Treat underlying cause ... Control rate (e.g ... Tachycardia #Treatment #management ... #cardiology #algorithm
Erythrocytosis - Polycythemia Differential Diagnosis Algorithm

Elevated Hemoglobin:
 • Males: Hb > 16.5 g/dL/HCT ≥ 49%
 •
Differential Diagnosis Algorithm ... Polycythemia - Acquired Causes ... Hypoxia-driven: Cardiac/pulmonary ... Paraneoplastic (e.g ... #hematology
Adult ACLS - Cardiac Arrest Algorithm - AHA 2020
CPR Quality:
 • Push hard (at least 2
Cardiac Arrest Algorithm ... recommendation (eg ... intra-arterial Reversible Causes ... , Thrombosis, (pulmonary ... #AHA2020 #management
Adult Cardiac Arrest - ACLS Circular Algorithm - AHA 2020
CPR Quality:
 • Push hard (at least
ACLS Circular Algorithm ... recommendation (eg ... intra-arterial Reversible Causes ... , Thrombosis, (pulmonary ... #AHA2020 #management
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... ECG is vital while ... the determined cause ... #differential #algorithm ... #management #cardiology
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
• Thrombosis (e.g ... ET-associated mutation (e.g ... thrombocytosis (e.g ... • Treatment algorithms ... #diagnosis #management